Conversely, a case–control study conducted in China through propensity score matching, which included 348 postmenopausal CAD cases and 348 controls, revealed that the AIP could potentially function as a robust predictor of CAD risk in postmenopausal women [60]. The gene discussed is AIP; the disease is coronary artery disorder.